Literature DB >> 7712964

Endoscopic therapy of biliary and pancreatic disorders in children.

K O Brown1, M Goldschmiedt.   

Abstract

Although many reports in the literature describe the use of endoscopic retrograde cholangiopancreatography (ERCP) in children, few mention the therapeutic application of the technique in treating pediatric patients with pancreatic or biliary pathology. We report here on our two-year experience, consisting of 42 ERCPs conducted in 25 patients for a variety of pancreaticobiliary indications. Ages ranged from 22 months to 19 years. Five patients had normal studies; the remainder were diagnosed with a variety of pancreatic and or biliary anomalies. Seventeen patients had therapeutic interventions consisting of sphincterotomy (n = 12), dilation (n = 6), or stent placement (n = 9), with many of these procedures being done in combination. Five patients had mild complaints of abdominal pain or vomiting immediately after ERCP, but no major technical or medical complications were encountered. We find that therapeutic ERCP can be safely performed in children, but only by highly experienced endoscopists familiar with these specialized procedures.

Entities:  

Mesh:

Year:  1994        PMID: 7712964     DOI: 10.1055/s-2007-1009082

Source DB:  PubMed          Journal:  Endoscopy        ISSN: 0013-726X            Impact factor:   10.093


  4 in total

1.  Progress in endoscopic management of pancreas diseases.

Authors:  Zhao-Shen Li
Journal:  World J Gastroenterol       Date:  1998-04       Impact factor: 5.742

2.  Diagnostic and therapeutic ERCP in the pediatric age group.

Authors:  Hussain Issa; Ali Al-Haddad; Ahmed H Al-Salem
Journal:  Pediatr Surg Int       Date:  2006-12-06       Impact factor: 1.827

3.  Sphincter of Oddi dysfunction in children.

Authors:  Moises Guelrud; Leonel Rodriguez
Journal:  Curr Gastroenterol Rep       Date:  2006-04

4.  Pediatric ERCP in a multidisciplinary community setting: experience with a fellowship-trained general surgeon.

Authors:  J A Green; D E Scheeres; H A Conrad; D L Cloney; M G Schlatter
Journal:  Surg Endosc       Date:  2007-05-19       Impact factor: 4.584

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.